PS Ratio
N/A
Thu, 06 Feb 2025 14:30:00 GMT
Summary
- NAVB price to sales ratio is not available.
Performance
NAVB PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
NAVB PS Ratio Trends
PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | - | 0.0% | 0.0% | - |
1 m1 month | - | 0.0% | 0.0% | - |
3 m3 months | - | -80.0% | -80.0% | - |
6 m6 months | - | -90.0% | -90.0% | - |
ytdytd | - | 0.0% | 0.0% | - |
1 y1 year | - | -99.7% | -99.7% | - |
5 y5 years | - | -100.0% | -100.0% | - |
NAVB PS Ratio Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | ||||
3 m | 3-month | ||||
6 m | 6-month | ||||
1 y | 1-year | ||||
3 y | 3-year | 1325.01 | 390.98 | ||
5 y | 5-year | 3973.38 | 234.67 | ||
alltime | all time | 5095.94 | -31 K |
Navidea Biopharmaceuticals PS Ratio History
Date | Value |
---|---|
2022 | 470.17(-29.2%) |
2021 | 664.03(+35.0%) |
2020 | 491.76(-45.8%) |
2019 | 907.72(+1360.8%) |
2018 | 62.14(-88.4%) |
2017 | 535.24(+885.3%) |
2016 | 54.32(-69.8%) |
2015 | 179.62(+297.0%) |
2014 | 45.24(-81.8%) |
2013 | 248.83(-93.9%) |
2012 | 4064.05(>+9900.0%) |
2010 | 30.45(+193.6%) |
2009 | 10.37(+97.9%) |
2008 | 5.24(+91.2%) |
Date | Value |
---|---|
2007 | 2.74(+16.1%) |
2006 | 2.36(-4.8%) |
2005 | 2.48(-57.2%) |
2004 | 5.79(+136.3%) |
2003 | 2.45(+155.2%) |
2002 | 0.96(-50.3%) |
2001 | 1.93(+69.3%) |
2000 | 1.14(-14.9%) |
1999 | 1.34(-51.4%) |
1998 | 2.76(-89.6%) |
1997 | 26.57(-90.8%) |
1996 | 289.41(+99.4%) |
1995 | 145.13(+867.5%) |
1994 | 15.00 |
FAQ
- What is the all time high PS ratio for Navidea Biopharmaceuticals?
What is the all time high PS ratio for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high price to sales ratio is 5095.94